Tagantiviral treatment

Australia leads the world in hepatitis C treatment – what’s behind its success?

A

The Conversation, July 31, 2017 4.05pm AEST The World Health Organisation recently set ambitious goals for the “elimination of hepatitis C as a major public health threat”. These included having 80% of people treated and an 80% reduction in the spread of the virus by 2030. Given there are around 70 million people infected with hep C worldwide, only 20% diagnosed, and no effective vaccine, the...

Australian Health Organisations refute Cochrane Review Report and affirm efficacy of DAA therapy for hepatitis C

A

Joint position statement, Australia, June 2017 This joint Position Statement aims to strongly refute and reject the findings of the Cochrane Review report titled Direct-acting antivirals for chronic hepatitis C, published by the Cochrane Hepato‐Biliary Group on 6 June 2017. The Position Statement was prepared by the expert panel who published a Consensus Statement for Australian recommendations...

Managing Chronic Hepatitis B – Advice for GPs (SHINE SA video)

M

SHINE SA, July 2017 Today, July 28th, is World Hepatitis Day. There are no ‘healthy carriers’ of hepatitis B! SA Health & SHINE SA are promoting a 6-minute video providing advice for general practitioners in diagnosing, managing and contact tracing patients with chronic hepatitis B (CHB), to assist in preventing serious liver disease. It is now known that people who were...

Hepatitis C treatment can be provided successfully at syringe programme sites

H

infohep.org, 18 April 2017
Administering direct-acting antiviral therapy for people who inject drugs at a syringe exchange site led to high sustained response rates in a pilot study in New York City. Expanding treatment for this population could reduce hepatitis C virus (HCV) transmission and ultimately help eliminate hepatitis C as a public health threat.

Read more here 

Australian recommendations for the management of hepatitis C infection – app & website

A

Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, July 2016 Chronic hepatitis C virus (HCV) infection is a major public health challenge for Australia, affecting approximately 230,000 people who are at risk of progressive liver fibrosis leading to cirrhosis, liver failure and hepatocellular carcinoma (HCC). The burden of liver disease due to HCV is projected to triple by...

Welcome to SASHA

SASHA is a current awareness service with news and views on various aspects of sexual health and sexuality, from a wide range of sources. These range from credible sources of sexual health and related information, to relevant opinion pieces in the media.

Categories